MECHANISMS OF RESISTANCE TO CHLORAMBUCIL IN CHRONIC LYMPHOCYTIC-LEUKEMIA

被引:20
作者
BEGLEITER, A
GOLDENBERG, GJ
ANHALT, CD
LEE, K
MOWAT, MRA
ISRAELS, LG
JOHNSTON, JB
机构
[1] UNIV MANITOBA,DEPT INTERNAL MED,WINNIPEG R3T 2N2,MANITOBA,CANADA
[2] UNIV MANITOBA,DEPT PHYSIOL,WINNIPEG R3T 2N2,MANITOBA,CANADA
[3] UNIV MANITOBA,DEPT PHARMACOL & THERAPEUT,WINNIPEG R3T 2N2,MANITOBA,CANADA
关键词
CHRONIC LYMPHOCYTIC LEUKEMIA; DRUG-RESISTANCE; CHLORAMBUCIL;
D O I
10.1016/0145-2126(91)90107-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The postulated biochemical mechanisms responsible for clinical resistance to chlorambucil (CLB) in chronic lymphocytic leukemia (CLL) have been examined. The total sulfhydryl, non-protein-bound sulfhydryl, protein-bound sulfhydryl (PSH) and glutathione (GSH) levels, in addition to glutathione S-transferase (GST) activities, were measured in the leukemic cells of 18 CLL patients. In addition, the formation and repair of DNA cross-links were measured following incubation of the cells with 100-mu-M chlorambucil in vitro. These parameters were then correlated with the subsequent clinical responses of the patients, as measured by the percent fall in lymphocyte count 3 weeks following 0.9 mg/kg chlorambucil. No correlations were observed between any of the individual parameters and clinical response, although a slight positive correlation was observed between the PSH:GSH ratio and clinical response. These findings suggest that multiple mechanisms may contribute to CLB-resistance in CLL.
引用
收藏
页码:1019 / 1027
页数:9
相关论文
共 36 条